Loading...

Julia Rohrberg, PhD

Title(s)Assoc Specialist, Cell and Tissue Biology
SchoolSchool of Dentistry
Address513 Parnassus Ave, HSW
San Francisco CA 94143
Phone415-476-4187
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. A phase Ib trial of the cyclin-dependent kinase inhibitor dinaciclib (dina) in combination with pembrolizumab (P) in patients with advanced triple-negative breast cancer (TNBC) and response correlation with MYC-overexpression. Journal of Clinical Oncology. 2020 May 20; 38(15_suppl):1076-1076. Amy Jo Chien, Amelia S Gliwa, Siti Rahmaputri, Heidi F Dittrich, Melanie Catherine Majure, Hope S. Rugo, Michelle E. Melisko, Pamela N. Munster, John W. Park, Mark M. Moasser, Mehrdad Matloubian, Tasha Lea, Julia Rohrberg, Gregor Krings, Andrei Goga. .
      View in: Publisher Site   Mentions:
    2. MYC Dysregulates Mitosis, Revealing Cancer Vulnerabilities. Cell Rep. 2020 Mar 10; 30(10):3368-3382.e7. Rohrberg J, Van de Mark D, Amouzgar M, Lee JV, Taileb M, Corella A, Kilinc S, Williams J, Jokisch ML, Camarda R, Balakrishnan S, Shankar R, Zhou A, Chang AN, Chen B, Rugo HS, Dumont S, Goga A. PMID: 32160543.
      View in: PubMed   Mentions:    Fields:    
    3. Aurora kinase A drives the evolution of resistance to third-generation EGFR inhibitors in lung cancer. Nat Med. 2019 01; 25(1):111-118. Shah KN, Bhatt R, Rotow J, Rohrberg J, Olivas V, Wang VE, Hemmati G, Martins MM, Maynard A, Kuhn J, Galeas J, Donnella HJ, Kaushik S, Ku A, Dumont S, Krings G, Haringsma HJ, Robillard L, Simmons AD, Harding TC, McCormick F, Goga A, Blakely CM, Bivona TG, Bandyopadhyay S. PMID: 30478424.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansAnimalsCells
    4. The Plasticity of the Hsp90 Co-chaperone System. Mol Cell. 2017 Sep 21; 67(6):947-961.e5. Sahasrabudhe P, Rohrberg J, Biebl MM, Rutz DA, Buchner J. PMID: 28890336.
      View in: PubMed   Mentions: 11     Fields:    Translation:AnimalsCells
    5. PIM1 kinase inhibition as a targeted therapy against triple-negative breast tumors with elevated MYC expression. Nat Med. 2016 11; 22(11):1321-1329. Horiuchi D, Camarda R, Zhou AY, Yau C, Momcilovic O, Balakrishnan S, Corella AN, Eyob H, Kessenbrock K, Lawson DA, Marsh LA, Anderton BN, Rohrberg J, Kunder R, Bazarov AV, Yaswen P, McManus MT, Rugo HS, Werb Z, Goga A. PMID: 27775705.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansAnimalsCells
    6. 367: Elucidating the synthetic lethal effect of CDK inhibition in triple negative breast cancer. European Journal of Cancer. 2014 Jul 1; 50:s88. J. Rohrberg, A. Corella, L. Starnes, A. Goga. .
      View in: Publisher Site   Mentions:
    7. Regulated structural transitions unleash the chaperone activity of aB-crystallin. Proc Natl Acad Sci U S A. 2013 Oct 01; 110(40):E3780-9. Peschek J, Braun N, Rohrberg J, Back KC, Kriehuber T, Kastenmüller A, Weinkauf S, Buchner J. PMID: 24043785.
      View in: PubMed   Mentions: 56     Fields:    Translation:HumansCells
    8. The chaperone Hsp90: changing partners for demanding clients. Trends Biochem Sci. 2013 May; 38(5):253-62. Röhl A, Rohrberg J, Buchner J. PMID: 23507089.
      View in: PubMed   Mentions: 86     Fields:    Translation:HumansAnimalsCells
    9. The regulatory domain stabilizes the p53 tetramer by intersubunit contacts with the DNA binding domain. J Mol Biol. 2013 Jan 09; 425(1):144-55. Retzlaff M, Rohrberg J, Küpper NJ, Lagleder S, Bepperling A, Manzenrieder F, Peschek J, Kessler H, Buchner J. PMID: 23103206.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCells
    10. Structural analysis of the interaction between Hsp90 and the tumor suppressor protein p53. Nat Struct Mol Biol. 2011 Sep 04; 18(10):1086-93. Hagn F, Lagleder S, Retzlaff M, Rohrberg J, Demmer O, Richter K, Buchner J, Kessler H. PMID: 21892170.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansCells
    11. Monitoring fibril formation of the N-terminal domain of PABPN1 carrying an alanine repeat by tryptophan fluorescence and real-time NMR. FEBS Lett. 2008 May 14; 582(11):1587-92. Rohrberg J, Sachs R, Lodderstedt G, Sackewitz M, Balbach J, Schwarz E. PMID: 18406354.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    Julia's Networks
    Concepts (80)
    Derived automatically from this person's publications.
    _
    Co-Authors (16)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _